Cargando…
Pharmacovigilance and assessment of drug safety reports during COVID 19
The speed and volume of clinical research to discover effective drug against novel corona virus has been remarkable. To address the unmet medical need, the regulations are made flexible and convenient without any relaxation in drug safety reporting. The pharmacovigilance activities, especially adver...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Wolters Kluwer - Medknow
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7513786/ https://www.ncbi.nlm.nih.gov/pubmed/33033703 http://dx.doi.org/10.4103/picr.PICR_171_20 |